Download PDF
Synlett 2006(12): 1938-1942  
DOI: 10.1055/s-2006-947350
LETTER
© Georg Thieme Verlag Stuttgart · New York

Efficient Access to Novel Mono- and Disubstituted Pyrido[3,2-d]pyrimidines

Abdellatif Tikada,b, Sylvain Routier*a, Mohamed Akssirab, Jean-Michel Legerc, Christian Jarryc, Gérald Guillaumeta
a ICOA UMR 6005 CNRS, Université d’Orléans, 45067, Orléans, France
Fax: +33(2)38417281; e-Mail: sylvain.routier@univ-orleans.fr;
b LCBA Université Hassan II-Mohammedia, BP 146, 20650 Mohammedia, Morocco
c EA 2962, Pharmacochimie, Université Victor Segalen Bordeaux II, France
Further Information

Publication History

Received 27 April 2006
Publication Date:
24 July 2006 (online)

    Permissions and Reprints All articles of this category

Abstract

New mono- and disubstituted pyrido[3,2-d]pyrimidines were synthesized starting from the corresponding 2,4-dichloro derivative through SNAr and palladium-catalyzed reactions. SNAr and palladium-catalyzed hydro-deshalogenation occurred selectively at position C-4. Further Suzuki cross-coupling led to C-2 and C-2,4 mono- and disubstituted compounds.

Key words

pyrimidines - palladium - Suzuki - SNAr - selectivity

12

Synthesis of 4.
A solution containing the 2,3-pyridine-carboxylic acid 2-methylester (2, 5 g, 27.62 mmol) and Et3N (5.05 mL, 1.3 equiv, 35.90 mmol) in dry THF (100 mL) was cooled at
-10 °C. Ethyl chloroformate (3.96 ml, 1.5 equiv, 41.33 mmol) was added dropwise and the reaction mixture was stirred at this temperature for 1.5 h. A solution of NaN3 (3.05 g, 1.7 equiv, 46.95 mmol) in H2O (35 mL) was then added in one portion. After 1.5 h at 0 °C, the resulting heterogeous mixture was filtered, the organic solvent was removed under reduced pressure and the aqueous phase was extracted with EtOAc (3 × 50 mL). The combined organic layers were dried over MgSO4, and concentrated in vacuo. The crude acyl azide was next dissolved in toluene (30 mL) and the solution was refluxed for 2 h. After cooling to r.t., a solution of 4-methoxybenzylamine (3.6 mL, 1 equiv, 27.62 mmol) in pyridine (30 mL) was added and the reaction mixture was refluxed for 24 h. The dark red solution was else evaporated to dryness and the residue was washed with EtOH (2 × 50 mL) and filtered to obtain compound 4 as a white solid (71% yield); mp 328-330 °C. IR (KBr): 3368, 3059, 2853, 1710, 1672, 1401, 1247, 809, 691 cm -1. 1H NMR (250 MHz, DMSO-d 6): δ = 3.70 (s, 3 H, OCH3), 5.02 (s, 2 H, CH2), 6.86 (d, 2 H, J = 8.5 Hz, HAr), 7.30 (d, 2 H, J = 8.5 Hz, HAr), 7.57-7.67 (m, 2 H, HPy), 8.49 (dd, 1 H, J = 1.6, 4.1 Hz, H6), 11.57 (s, 1 H, NH, exchangeable D2O) ppm. 13C NMR (62.5 MHz, DMSO-d 6) δ = 42.7 (CH2), 54.7 (CH3), 113.4 (2 CH), 123.4 (CH), 128.6 (CH), 128.9 (Cq), 129.0 (2 CH), 130.5 (Cq), 136.5 (Cq), 144.8 (CH), 149.4 (Cq), 158.1 (CO), 160.2 (CO) ppm. HRMS (EI-MS): m/z calcd for C15H13N3O3: 283.0956; found: 283.0967.

15

Preparation of 6.
A mixture of 1H,3H-pyrido[3,2-d]pyrimidine-2,4-dione (5, 1 g, 5 mmol), POCl3 (10 mL) and PCl5 (5.41 g, 4 equiv) was refluxed for 4 h then cooled to r.t. Excess POCl3 was evaporated and the residue neutralized with aq Na2CO3 and extracted with CH2Cl2. The combined organic layers were dried over MgSO4, and concentrated in vacuo. The residue was purified by flash chromatography (PE-EtOAc, 8:2) to afford compound 6 as a pale yellow solid (58% yield); mp 168-169 °C. IR (KBr): 3068, 1537, 1462, 1443, 1369, 1186, 1107, 878, 831, 794 cm-1. 1H NMR (250 MHz, CDCl3): d = 7.92 (dd, 1 H, J = 4.1, 8.5 Hz, H7), 8,33 (dd, 1 H, J = 1.6, 8.5 Hz, H8), 9.14 (dd, 1 H, J = 1.6, 4.1 Hz, H6) ppm. 13C NMR (62.5 MHz, CDCl3): d = 130.3 (CH), 136.3 (CH), 137.1 (Cq), 149.0 (Cq), 153.2 (CH), 155.8 (Cq), 166.2 (Cq) ppm. HRMS (EI-MS): m/z calcd for C7H3 35Cl2N3: 198.9704; found: 198.9715.

23

Preparation of 9.
A solution containing the 2,4-dichloropyrido[3,2-d]pyrimi-dine (6, 500 mg, 2.5 mmol) in dry THF (25 mL) was cooled at 0 °C. Then, a prebuilt suspension of 2-propanethiol (0.232 mL, 1 equiv) and NaH (105 mg, 60% in oil, 1.05 equiv) in dry THF (15 mL) was dropwise added. The reaction mixture was allowed to r.t. and stirred overnight. Hydrolysis was realized with cold H2O (30 mL) and the aqueous layers were extracted with EtOAc (3 × 20 mL). The combined organic layers were dried on MgSO4, filtered and evaporated under reduced pressure. The crude residue was purified by silica gel column chromatography (PE-EtOAc, 8:2) to afford compound 9 (88% yield); mp 93-94 °C. IR (KBr): 2963, 1555, 1518, 1458, 1426, 1334, 1169, 1110, 876, 853, 821, 720 cm-1. 1H NMR (250 MHz, CDCl3): δ = 1.48 (d, 6 H, J = 6.9 Hz, 2 CH3), 4.18 (m, 1 H, J = 6.9 Hz, CH), 7.73 (dd, 1 H, J = 4.1, 8.5 Hz, H7), 8.11 (dd, 1 H, J = 1.6, 8.5 Hz, H8), 8.84 (dd, 1 H, J = 1.6, 4.1 Hz, H6) ppm. 13C NMR ( 62.5 MHz, CDCl3): δ = 22.6 (2 CH3), 35.3 (CH), 129.1 (CH), 135.9 (CH), 137.9 (Cq), 145.1 (Cq), 150.3 (CH), 156.5 (Cq), 178.1 (Cq) ppm. HRMS (EI-MS): m/z calcd for C10H10 35ClN3S: 239.02840; found: 239.0273.

24

Diffraction data were collected using a CAD4 Enraf-Nonius. Full crystallographic results have been deposited as Supplementary Materials at the Cambridge Crystallographic Data Centre, University Chemical Lab, 12 Union Road, Cambridge CB2 1EZ UK; e-mail: deposit@ccdc.cam.ac.uk.

25

Preparation of 21.
To a solution of 2-chloro-4-isopropylsulfanylpyrido[3,2-d]pyrimidine (9, 100 mg, 0.42 mmol) in DME (6 mL) were successively added 4-methoxyphenylboronic acid (76 mg, 1.2 equiv) and a solution of Na2CO3 (89 mg, 2 equiv) in H2O (3 mL) and Pd(PPh3)4 (24 mg, 0.05 equiv). The reaction mixture was heated at 75 °C under vigorous stirring under argon atmosphere. After complete disappearance of 9, the solution was concentrated in vacuo and the residue diluted in H2O (10 mL). After extraction with CH2Cl2 (3 × 20 mL), the dried organic layers were evaporated to dryness. The crude material was purified by flash column chromatography (PE-CH2Cl2, 3:7) to afford compound 21 as a white solid (85% yield); mp 125-126 °C. IR (KBr): 2954, 1600, 1587, 1536, 1458, 1435, 1376, 1165, 839, 821, 747, 696 cm-1. 1H NMR (250 MHz, CDCl3): δ = 1.58 (d, 6 H, J = 6.9 Hz, 2 CH3), 3.86 (s, 3 H, OCH3), 4.33 (m, 1 H, J = 6.9 Hz, CH), 7,00 (d, 2 H, J = 8.8 Hz, H3 ′), 7.65 (dd, 1 H, J = 4.1, 8.5 Hz, H7), 8.17 (dd, 1 H, J = 1.0, 8.5 Hz, H8), 8.53 (d, 2 H, J = 8.8 Hz, H2 ′), 8.78 (dd, 1 H, J = 1.0, 4.1 Hz, H6) ppm. 13C NMR (62.5 MHz, CDCl3): δ = 22.7 (2 CH3), 34.6 (CH), 55.4 (CH3), 113.9 (CH), 128.3 (CH), 130.2 (Cq), 130.5 (CH), 136.6 (CH), 138.0 (Cq), 144.4 (Cq), 149.0 (CH), 159.5 (Cq), 162.1 (Cq), 173.8 (Cq). HRMS (EI-MS): m/z calcd for C17H17N3OS: 311.10923; found: 311.1116.

27

Synthesis of 25.
A solution of 2,4-dichloropyrido[3,2-d]pyrimidine (6, 1.0 g, 5 mmol), Bu3SnH (1.48 mL, 1.1 equiv, 5.5 mmol) in toluene (60 mL) was degassed by argon bubbling during 30 min. Then, Pd(PPh3)4 (290 mg, 0.05 equiv, 0.25 mmol) was added in one portion and the reaction mixture was placed in a pre-heated oil 100 °C for 1 h. After cooling to r.t., the solvent was evaporated in vacuo and a sat. solution of KF (20 mL) was added. After filtration, the aqueous layers were extracted with EtOAc (3 × 25 mL). The combined organic layers were dried over MgSO4, and concentrated in vacuo. The crude material was purified by flash chromatography (PE-EtOAc, 8:2) to afford compound 25 as a white solid (86% yield); mp 119-120 °C. IR (KBr): 3059, 1560, 1462, 1439, 1359, 1154, 1098, 873, 822, 696 cm-1. 1H NMR (250 MHz, CDCl3): δ = 7.89 (dd, 1 H, J = 4.1, 8.5 Hz, H7), 8.32 (d, 1 H, J = 8.5 Hz, H8), 9.11 (dd, 1 H, J = 1.6, 4.1 Hz, H6), 9.54 (s, 1 H, H4) ppm. 13C NMR (62.5 MHz, CDCl3): δ = 129.5 (CH, C7), 135.6 (CH, C8), 139.2 (Cq, C4a), 148.6 (Cq, C8a), 153.0 (CH, C6), 158.0 (Cq, C2), 164.6 (CH, C4) ppm. HRMS (EI-MS): m/z calcd for C7H4N3 35Cl: 165.00937; found: 165.0104.